Cargando…
Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
Dyslipidemia is a fundamental risk factor for cardiovascular diseases (CVDs) and can worsen the prognosis, if unaddressed. Lipid guidelines are still evolving as dyslipidemia is affecting newer patient subsets. However, these guidelines are governed by regional demographics and ethnic data. Primary...
Autores principales: | Thongtang, Nuntakorn, Sukmawan, Renan, Llanes, Elmer Jasper B., Lee, Zhen-Vin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152805/ https://www.ncbi.nlm.nih.gov/pubmed/35656215 http://dx.doi.org/10.1016/j.pmedr.2022.101819 |
Ejemplares similares
-
Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region
por: Lee, Zhen-Vin, et al.
Publicado: (2021) -
Injection of an improperly stored proprotein convertase subtilisin/kexin type 9 monoclonal antibody in a patient with secondary dyslipidemia from nephrotic syndrome: a case report
por: Kongmalai, Tanawan, et al.
Publicado: (2023) -
Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
por: Thongtang, Nuntakorn, et al.
Publicado: (2020) -
2304. Incidence and Risk Factors for Herpes Zoster among Diabetes Patients at Siriraj Hospital; Results from a 10-year Cohort
por: Chuanchaiyakul, Nalinee, et al.
Publicado: (2019) -
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East
por: Alshamiri, Mostafa, et al.
Publicado: (2018)